Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 140 recruiting studies, sorted by proximity — each links to its official registry page
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology - Central South (South 2nd) — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Nova Oncology — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Integrative Rheumatology of South Texas — Edinburg, Texas (7.4 mi)
· Sponsor: Pfizer
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
HCA Research Institute — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology McAllen — McAllen, Texas (1.8 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 911 participants sought
GSK Investigational Site — Pharr, Texas (4.4 mi)
· Sponsor: GlaxoSmithKline
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 36 — Mission, Texas (4.9 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
A & A Research Consultants, LLC — McAllen, Texas (1.8 mi)
· Sponsor: United Therapeutics
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
Elevate Clinical — McAllen, Texas (1.8 mi)
· Sponsor: Hoffmann-La Roche
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Edinburg, Texas (7.4 mi)
· Sponsor: Hoffmann-La Roche
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Valley Retina Institute, P.A. — McAllen, Texas (1.8 mi)
· Sponsor: ONL Therapeutics
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Overweight, Obesity
Phase 2
Interventional 400 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Eli Lilly and Company
A Randomized Control Trial of Conversations Advancing Resilience and Empowerment (CARE) Intervention
Quality of Life, Health Promotion
N/A
Interventional 200 participants sought
The University of Texas at Rio Grande Valley — Edinburg, Texas (7.4 mi)
· Sponsor: University of Texas Rio Grande Valley
ProACT Post-Approval Study
Stress Urinary Incontinence
N/A
Interventional 145 participants sought
DHR Health Institute for Research and Development — McAllen, Texas (1.8 mi)
· Sponsor: Uromedica
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
Influenza a, Influenza B
N/A
Interventional 1,000 participants sought
PAS Research - McAllen — McAllen, Texas (1.8 mi)
· Sponsor: DiaSorin Molecular LLC
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 734 participants sought
DHR Health Oncology Institute — Edinburg, Texas (7.4 mi)
· Sponsor: NovoCure GmbH
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
DHR Health Headache Center — McAllen, Texas (1.8 mi)
· Sponsor: Mayo Clinic
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — McAllen, Texas (1.8 mi)
· Sponsor: Dogwood Therapeutics Inc.
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Graves' Disease, Graves Disease
Phase 3
Interventional 230 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: argenx
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 3
Interventional 160 participants sought
MBX Biosciences Investigational Site — Edinburg, Texas (7.4 mi)
· Sponsor: MBX Biosciences
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Geographic Atrophy
Phase 1, Phase 2
Interventional 152 participants sought
Valley Retina Institute, PA — McAllen, Texas (1.8 mi)
· Sponsor: Biojiva LLC
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology -Central South — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer